ACHE and Alzheimer disease: A significant correlation between the inhibition of BChE activity in the cerebrospinal fluid (CSF), but not AChE, with an enhancement in cognitive performance in patients with mild to moderate AD after treatment with rivastigmine (non-specific inhibitor of cholinesterases) has been reported [14].